Quoin Pharmaceuticals QNRX Growth Metrics (2017-2026)

NASDAQ QNRX
$3.90 +0.27 (+7.44%)
At close: Nov 9, 2026 · 4:00 PM EST
Reported Financials

Quoin Pharmaceuticals Quarterly Growth Metrics

Periods 27 quarters
Latest Sep 2026

Quoin Pharmaceuticals reported asset growth of 32.12% for the quarter ended Sep 2026. These growth metrics cover 27 quarters of results from Dec 2017 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Dec2017 Dec2018 Jun2019 Dec2019 Jun2020 Dec2020 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Growth Ratios
Share-based Compensation (QoQ)Stock Comp. (QoQ)
16.37%0.00%-2.07%0.97%1.89%11.60%2.04%2.18%0.00%4.47%10.20%-10.92%-43.30%57.13%55.61%19.55%-9.02%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y)
11.84%-11.99%2.31%19.39%26.31%21.63%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
15.06%0.75%12.43%17.15%18.56%16.36%8.93%17.64%2.56%-41.85%-12.55%23.49%65.73%165.93%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y)
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
-741.59%85.76%-58.56%-15.99%35.35%-30.09%19.06%8.56%-6.39%-13.53%15.18%-19.04%1.64%-64.94%3.05%-6.82%-9.03%-16.10%-7.47%9.31%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
-4.37%-28.24%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
23.08%-18.73%41.95%-31.33%-11.47%-8.46%-29.09%-24.29%-36.61%-36.23%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
38.49%-120.41%83.07%-54.69%21.03%37.75%-2.44%10.59%6.31%-21.97%-12.75%-63.80%-87.23%-68.02%-86.25%-31.10%-45.32%-23.37%
Net Income (QoQ)
-741.59%85.76%-58.56%-13.54%33.95%-30.09%19.06%8.56%-6.39%-13.53%15.18%-19.04%1.64%-64.94%3.05%-6.82%-10.14%-14.93%-7.47%9.31%
Net Income Growth (5y)
-28.24%
Net Income Growth (3y)
-18.73%41.95%-31.33%-11.47%-9.23%-29.53%-24.29%-36.61%-36.23%
Net Income Growth (1y)
-115.76%83.07%-54.69%21.03%36.40%-2.44%10.59%6.31%-21.97%-12.75%-63.80%-87.23%-68.02%-88.14%-31.10%-45.32%-23.37%
Net Cash Flow (QoQ)NCF (QoQ)
739.63%-133.58%-9.06%202.42%-193.26%121.40%171.36%-215.02%52.23%25.52%278.20%-73.15%86.51%-60.76%-1,183.43%107.54%1,123.91%-134.91%203.96%766.45%
Net Cash Flow Growth (5y)NCF Growth (5y)
51.02%
Net Cash Flow Growth (3y)NCF Growth (3y)
31.12%-57.98%27.79%4.87%-60.13%41.48%-49.74%-19.58%80.88%
Net Cash Flow Growth (1y)NCF Growth (1y)
339.93%-134.98%122.29%155.46%-162.28%68.10%-211.04%-27.08%117.02%166.46%135.02%-312.89%-40.21%292.39%-449.15%133.50%3,749.10%
Free Cash Flow (QoQ)FCF (QoQ)
-250.27%34.14%-2.76%-6.60%15.31%10.08%9.95%15.97%-143.93%55.50%-39.93%-8.58%-2.63%-15.99%-42.10%39.63%-126.25%3.30%35.42%-83.49%
Free Cash Flow Growth (5y)FCF Growth (5y)
-44.76%
Free Cash Flow Growth (3y)FCF Growth (3y)
-33.91%11.06%-7.41%-19.66%1.00%-37.37%-40.74%-25.98%-63.44%
Free Cash Flow Growth (1y)FCF Growth (1y)
-152.71%38.90%16.58%26.90%42.38%-65.97%17.87%-27.62%-64.91%30.62%-80.86%-83.66%-2.12%-125.13%-87.69%14.70%-159.26%
EPS (Diluted) (QoQ)
-537.98%-33,539.58%-1,451.33%71.00%92.68%58.80%-526.94%8.56%-16.59%51.37%64.67%-19.04%-5.93%-1,218.97%3.35%-6.82%39.96%56.19%-7.40%49.05%
EPS (Diluted) Growth (5y)
-249.99%-283.23%
EPS (Diluted) Growth (3y)
-376.63%-635.69%-304.36%-37.37%45.54%15.89%-69.59%-73.09%3.87%20.90%
EPS (Diluted) Growth (1y)
-1,077,668.96%-965,250.28%-10,980.88%86.43%94.51%82.70%-175.40%-225.04%81.68%76.16%78.34%-487.60%-1,507.45%-1,342.50%-717.54%72.85%69.83%85.61%
EPS (Basic) (QoQ)
-95.45%-33,539.58%-1,451.33%71.00%92.68%58.80%-526.94%8.56%-16.59%51.37%64.67%-19.04%-5.93%-1,218.97%3.35%-6.82%39.96%56.19%-7.40%49.05%
EPS (Basic) Growth (5y)
-176.25%-202.48%
EPS (Basic) Growth (3y)
-221.31%-395.95%-304.36%-37.37%45.54%15.89%-69.59%-73.09%3.87%20.90%
EPS (Basic) Growth (1y)
-330,084.63%-295,644.11%-10,980.88%86.43%94.51%82.70%-175.40%-225.04%81.68%76.16%78.34%-487.60%-1,507.45%-1,342.50%-717.54%72.85%69.83%85.61%
Cash from Operations (QoQ)Cash from Ops. (QoQ)
-250.27%34.14%-2.76%-6.60%15.31%10.08%9.95%15.97%-143.93%55.50%-39.93%-8.58%-2.63%-15.99%-42.10%39.63%-126.25%3.30%35.42%-83.49%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
-44.76%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
-33.91%11.06%-7.41%-19.66%1.00%-37.37%-40.74%-25.98%-63.44%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
-152.71%38.90%16.58%26.90%42.38%-65.97%17.87%-27.62%-64.91%30.62%-80.86%-83.66%-2.12%-125.13%-87.69%14.70%-159.26%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ)
-132.56%80.00%-300.00%-4,849.56%186.93%-99.97%321,946.29%-268.90%170.65%-17.57%-222.20%187.15%-39.25%50.82%-544.01%136.55%-2.46%-500.45%
Cash from Investing Activities Growth (5y)Cash from Investing Growth (5y)
-172.29%
Cash from Investing Activities Growth (3y)Cash from Investing Growth (3y)
196.98%-133.39%285.75%118.37%31.16%47.05%9.80%-2,596.17%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y)
-9,108.48%-6,883.01%1,617.50%100.01%-27.90%3.95%316,685.75%-220.21%162.03%-46.67%-2.42%-254.54%48.70%138.77%-733.97%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
95.32%-45.51%18.86%41.18%-33.33%-24.96%-23.64%55.17%9.55%16.25%5.49%-55.52%7.70%108.54%-18.17%23.08%162.64%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
35.51%-6.40%-3.40%-12.69%-17.90%-7.09%-24.75%-6.28%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
16.49%-29.37%-18.24%-12.01%-23.10%-21.47%-14.16%-29.61%10.10%-2.78%-7.12%46.69%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
41.74%-61.77%78.58%-39.05%-16.06%-46.07%-40.73%-2.60%50.90%108.46%-40.25%-41.26%5.37%-18.25%126.21%451.64%
Assets (QoQ)
280.41%-12.05%27.62%-9.44%-9.82%-19.24%32.49%-12.83%-18.97%37.93%-17.53%-31.20%-27.93%217.43%-23.04%-23.73%190.30%
Assets Growth (5y)
1.14%10.43%13.23%17.28%10.01%20.58%2.13%27.33%
Assets Growth (3y)
19.49%-20.87%32.88%27.71%25.93%18.85%27.29%-26.89%12.14%-5.25%-10.52%32.12%
Assets Growth (1y)
53.56%54.52%286.68%-8.34%-15.83%-12.61%-15.89%-24.41%29.09%-19.65%-36.59%-43.60%29.80%21.13%34.30%440.92%

Quoin Pharmaceuticals Growth Metrics API

Pull Quoin Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=QNRX&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY